Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:JNJ NYSE:JPM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$228.32+2.3%$232.25$149.04▼$251.71$549.63B0.268.35 million shs7.27 million shsJPMJPMorgan Chase & Co.$310.99+3.4%$303.16$260.31▼$337.25$833.29B110.08 million shs10.34 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+0.27%-3.36%-1.72%-6.70%+44.77%JPMJPMorgan Chase & Co.-0.08%+0.68%-3.78%+2.65%+13.04%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeJNJJohnson & Johnson$228.32+2.3%$232.25$149.04▼$251.71$549.63B0.268.35 million shs7.27 million shsJPMJPMorgan Chase & Co.$310.99+3.4%$303.16$260.31▼$337.25$833.29B110.08 million shs10.34 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceJNJJohnson & Johnson+0.27%-3.36%-1.72%-6.70%+44.77%JPMJPMorgan Chase & Co.-0.08%+0.68%-3.78%+2.65%+13.04%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceJNJJohnson & Johnson 2.74Moderate Buy$253.0410.83% UpsideJPMJPMorgan Chase & Co. 2.48Hold$339.089.04% UpsideCurrent Analyst Ratings BreakdownLatest JNJ and JPM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/13/2026JNJJohnson & Johnson Johnson RiceSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Outperform5/13/2026JNJJohnson & Johnson Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeMarket Perform ➝ Outperform$265.005/12/2026JPMJPMorgan Chase & Co. Dbs BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/6/2026JPMJPMorgan Chase & Co. UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price Target$380.00 ➝ $375.005/6/2026JPMJPMorgan Chase & Co. BarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026JPMJPMorgan Chase & Co. Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026JPMJPMorgan Chase & Co. HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$288.00 ➝ $312.005/4/2026JPMJPMorgan Chase & Co. Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral4/24/2026JNJJohnson & Johnson Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy (B+) ➝ Buy (B)4/20/2026JNJJohnson & Johnson GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$244.00 ➝ $266.004/17/2026JPMJPMorgan Chase & Co. EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$320.00 ➝ $340.00(Data available from 6/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookJNJJohnson & Johnson$94.19B5.84$14.46 per share15.79$33.85 per share6.75JPMJPMorgan Chase & Co.$280.35B2.97$25.35 per share12.27$125.78 per share2.47Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateJNJJohnson & Johnson$26.80B$8.6526.4018.122.1821.83%32.60%13.29%7/15/2026 (Estimated)JPMJPMorgan Chase & Co.$57.05B$20.8814.8913.181.4720.66%17.54%1.30%7/14/2026 (Estimated)Latest JNJ and JPM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/14/2026Q1 2026JNJJohnson & Johnson$2.68$2.70+$0.02$2.14$23.60 billion$24.06 billion4/14/2026Q1 2026JPMJPMorgan Chase & Co.$5.50$5.94+$0.44$5.94$48.30 billion$50.54 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthJNJJohnson & Johnson$5.362.35%+5.25%61.97%64 YearsJPMJPMorgan Chase & Co.$6.001.93%+9.04%28.74%15 YearsLatest JNJ and JPM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/18/2026JPMJPMorgan Chase & Co.quarterly$1.501.99%7/6/20267/6/20267/31/20264/14/2026JNJJohnson & Johnsonquarterly$1.342.33%5/26/20265/26/20266/9/20263/17/2026JPMJPMorgan Chase & Co.quarterly$1.502.03%4/6/20264/6/20264/30/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioJNJJohnson & Johnson0.461.030.77JPMJPMorgan Chase & Co.1.300.860.86Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipJNJJohnson & Johnson69.55%JPMJPMorgan Chase & Co.71.55%Insider OwnershipCompanyInsider OwnershipJNJJohnson & Johnson0.16%JPMJPMorgan Chase & Co.0.41%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableJNJJohnson & Johnson138,2002.41 billion2.40 billionOptionableJPMJPMorgan Chase & Co.318,5122.68 billion2.67 billionOptionableJNJ and JPM HeadlinesRecent News About These CompaniesJ.P. Morgan Lifts Stake in a2 Milk to More Than 6%3 minutes ago | tipranks.comJPMorgan Entities Exit Substantial Holder Position in PLS Group3 minutes ago | tipranks.comJPMorgan, Citi and Big Banks Plan New Tokenized Deposit System to Answer Crypto56 minutes ago | wsj.comJPMorgan Chase & Co. (NYSE:JPM) Trading 3.4% Higher - What's Next?1 hour ago | marketbeat.comJamie Dimon Pitches SpaceX IPO To 2,500 Wealthy JPMorgan Clients Thursday3 hours ago | benzinga.comBanking On Breakouts: UBS, Citi Charts Shape Up4 hours ago | finance.yahoo.com$1B J.P. Morgan Advisor Joins Cresset to Expand Denver Footprint4 hours ago | wealthmanagement.comWJPMorgan Mobilizes 2,500 Clients Ahead Of $1.8 Trillion SpaceX IPO4 hours ago | finance.yahoo.comJPMorgan Chase & Co (JPM) on the Lookout for Acquisition Opportunities4 hours ago | finance.yahoo.comJPMorgan: CLARITY Act Has Only A Narrow Window To Succeed, Timing Is 'Pivotal'June 4 at 2:31 PM | benzinga.comJPMorgan Chase & Co (JPM) on the Lookout for Acquisition OpportunitiesJune 4 at 2:30 PM | insidermonkey.comJPMorgan Stock Rises As Investors Rotate Into FinancialsJune 4 at 1:10 PM | benzinga.comJPMorgan's Jamie Dimon to pitch Elon Musk's SpaceX IPO to uber-rich clientsJune 4 at 1:08 PM | nypost.comNVTI is up 0.2% today, on JPM stock price movementJune 4 at 12:31 PM | quiverquant.comQJPMorgan's Jamie Dimon to flex massive branch network in SpaceX IPO pitchJune 4 at 11:51 AM | finance.yahoo.comHow Much Would a $10,000 Investment in JPMorgan Chase Stock 10 Years Ago Be Worth Today?June 4 at 11:10 AM | fool.comJamie Dimon sees ‘gung-ho’ attitude and ‘exuberance’ in markets—just like 1972, 1986, 2000 and 2007. Uh Oh.June 4 at 10:10 AM | fortune.comHow The Standard Life (LSE:SDLF) Narrative Is Shifting With Aegon UK And Capital Light GrowthJune 4 at 9:59 AM | finance.yahoo.comIs JPMorgan Diversified Return Emerging Markets Equity ETF (JPEM) a Strong ETF Right Now?June 4 at 9:59 AM | finance.yahoo.comDeutsche Bank shuns “aggressive” promotions to beat rivalsJune 4 at 9:59 AM | retailbankerinternational.comR'The chokepoints now run both ways': JPMorgan says 5 forces are quietly reshaping the US-China balance of powerJune 4 at 9:59 AM | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 2026Apple Talks Just Changed Everything for IntelBy Sam Quirke | May 6, 2026IonQ Just Posted a Breakout Quarter—But 1 Problem RemainsBy Nathan Reiff | May 7, 2026Before the Moon Base Gets Built, These 4 Companies WinBy Thomas Hughes | May 11, 20263 Dividend Kings That Earn Their Crown Every QuarterBy Chris Markoch | May 31, 2026JNJ and JPM Company DescriptionsJohnson & Johnson NYSE:JNJ$228.32 +5.08 (+2.28%) Closing price 03:59 PM EasternExtended Trading$228.06 -0.27 (-0.12%) As of 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.JPMorgan Chase & Co. NYSE:JPM$310.98 +10.14 (+3.37%) Closing price 03:59 PM EasternExtended Trading$310.79 -0.19 (-0.06%) As of 07:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. It focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand Medtronic Bottoms, Healthy Rebound Ahead From Runway to Riches: Victoria's Secret's New Look Coke's $10B India IPO Plan Pops the Top on Hidden Value Dell's AI Toll Bridge Is Paved with Record Margins The Blue Origin Explosion Is a Setback for Amazon, Not a Dealbreaker GitLab’s Price Recovery Gains Traction—Time to Get On Board? Ulta's Q1 Report Primes It for a Beauty of a Rebound Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
